A simple, fast, and affordable COVID-19 test kit that detects viruses without having to draw blood or swab high up the nasal passage.

ASSURE-100 Rapid COVID-19 Tests have been authorized by the FDA under an emergency use authorization. The test has been authorized only for the detection of SARS-CoV-2, not for any other viruses or pathogens.


A scientist preparing an object inside a large machine

Developed with AI to examine biological causality in genomic codes

ASSURE tests are a novel approach to rapid, point-of-need testing for viruses. They’re built upon Oceanit’s TRIAD platform technology, an advanced Artificial Intelligence system developed in partnership with the Office of Naval Research (ONR) and the Defense Advanced Research Projects Agency (DARPA) to examine biological causality in genomic codes. Originally developed to support cancer research, the technology was reengineered to respond to the SARS-CoV-2 virus.

ASSURE (Accelerated Sensor Solution for Urgent Response to Epidemics) is a simple, fast, and affordable test that detects viruses without having to draw blood or swab high up the nasal passage. The test cassettes are similar to a home pregnancy test, or Lateral Flow Assays (LFAs). AI-engineered molecules in ASSURE’s buffer solution detect the presence of a specific virus or viral particle. If the virus is not present, a single control line will appear. If the virus is detected, a second positive test line will appear.

Tubes inserted into a COVID-19 test box.

A shallow swab and fast results

Oceanit’s powerful AI can be used to design the required molecular chemistry for a virus of choice, providing a response to the presence of the virus by matching to that virus’s genomic code. Development involved the decoding of the COVID-19 virus genomic code to custom build a response molecule for a specific protein within the SARS-CoV-2 virus.

With ASSURE, the test specimen (a swabbed saliva or nasal sample) doesn’t need to be processed through the conventional, time-consuming laboratory technique known as polymerase chain reaction, or PCR, in which a machine cycles through several temperature changes to amplify genetic material. Instead, after shaking for a few seconds to mix, the specimen is applied to the test cassette and the result appears in just minutes. ASSURE tests are a simple, safe, reliable, and effective testing platform that enables affordable, rapid, highly specific testing.

ASSURE-100 quickly and reliably detects all variants of COVID-19.

Developed in Hawaiʻi, ASSURE-100 is a shallow nasal antigen test that’s simple, fast, and accurate.

The ASSURE-100 Rapid COVID-19 Test has been authorized by the U.S. FDA under an emergency use authorization for use by CLIA and CLIA waived laboratories in Point of Care settings. The ASSURE-100 Rapid COVID-19 Test is for use by authorized laboratories for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless authorization is terminated or revoked sooner. The ASSURE-100 Rapid COVID-19 Test has not been FDA approved.

Commercialization

To learn more or buy a test kit, visit the ASSURE website.

ASSURE COVID-19 Tests

Related products

Privacy Preference Center